Evolution of the probiotic concept: From conception to validation and acceptance in medical science

Advances in Applied Microbiology

Volumn 72, Issue C, 2010, Pages 1-41

  Dobrogosz, Walter J ^a   Peacock, Trent J ^b   Hassan, Hosni M ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b U S ARMY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ATCC 55700; ATCC 55730; CHOLERA TOXIN B SUBUNIT; CYTOKINE; IMMUNOLOGICAL ADJUVANT; OMEPRAZOLE; PLACEBO; PROBIOTIC AGENT; SIMETHICONE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VACCINE;

ABSENCE OF SIDE EFFECTS; ACUTE DIARRHEA; ANTIBACTERIAL ACTIVITY; ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; CLINICAL TRIAL; COLD STRESS; COLIC; COLITIS; CYTOKINE PRODUCTION; DEFECATION HABIT; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DNA MODIFICATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; DYSPEPSIA; EUKARYOTE EVOLUTION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SYMPTOM; GINGIVITIS; HELICOBACTER INFECTION; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; INFECTION; INFECTION PREVENTION; INFECTION SENSITIVITY; INTESTINE EPITHELIUM CELL; LACTOBACILLUS; LACTOBACILLUS GASSERI; LACTOBACILLUS JOHNSONII; LACTOBACILLUS REUTERI; MICROBIOME; NONHUMAN; NUTRITIONAL TOLERANCE; OCCUPATIONAL HEALTH; OSMOTIC STRESS; OXIDATIVE STRESS; PREMATURITY; REGULATORY T LYMPHOCYTE; ROTAVIRUS INFECTION; STREPTOCOCCUS MUTANS; T LYMPHOCYTE; TOOTH PLAQUE; VALIDATION PROCESS; WORKPLACE;

BACILLI (CLASS);

EID: 77954307663     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2164(10)72001-3     Document Type: Chapter

References (157)

1. Altermann E., Buck L.B., Cano R., Klaenhammer T.R. Identification and phenotypic characterization of the cell-divison protein CdpA. Gene 2004, 342:189-197.
2. Andersson H., Asp N.-G., Bruse A., Roos S., Wadstrom T., Wold A.E. Health effects of probiotics and prebiotics: A literature review on human studies. Scand. J. Nutr. 2001, 45:58-75.
3. Andrus J.M., Bowen S.W., Klaenhammer T.R., Hassan H.M. Molecular characterization and functional analysis of the manganese-containing superoxide dismutase gene (sodA) from Streptococcus thermophilus AO54. Arch. Biochem. Biophys. 2003, 420:103-113.
4. Atlas R.M. Probiotics-Snake oil for the new millennium?. Environ. Microbiol. 1999, 1:375-382.
5. Avall-Jääskeläinen S., Palva A. Lactobacillus surface layers and their applications. FEMS Microbiol. Rev. 2005, 29:511-529.
6. Banchereau J., Steinman R.M. Dendritic cells and control of immunity. Nature 1998, 392:245-252.
7. Barrow P.A. Probiotics for chickens. Probiotics: The Scientific Basis 1992, Chapman and Hall, London. R. Fuller (Ed.).
8. Beg A.A. Comppartmentalizing NF-kB in the gut. Nat. Immunol. 2004, 5:14-16.
9. Berg R.D. Probiotics, prebiotics or 'conbiotics'?. Trends Microbiol. 1998, 6:89-92.
10. Bibel D.J. Elie Metchnikoff's Bacillus of long life. Am. Soc. Microbiol. News 1988, 54:661-665.
11. Bonhoff M., Miller P.C., Martin W.R. Effect of streptomycin in susceptibility of intestinal tract to experimental Salmonella infection. Proc. Soc. Exp. Biol. Med. 1954, 86:132-137.
12. Braat H., Rottiers P., Hommes D.W., Huyghebaert N., Remaut E., Remon J.P., van Deventer S.J., Neirynck S., Peppelenbosch M.P., Steidler L. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 2006, 4:754-759.
13. Bruno-Barcena J.M., Andrus J.M., Libby S.L., Klaenhammer T.R., Hassan H.M. Expression of a heterlogous manganese superoxide dismutase gene in intestinal lactobacilli: Protection against the toxicity of hydrogen peroxide. Appl. Environ. Microbiol. 2004, 70:4702-4710.
14. Bruno-Barcena J.M., Azcarate-Peril M.A., Klaenhammer T.R., Hassan H.M. Marker-free chromosomal integration of the manganese superoxide dismutase gene (sodA) from Streptococcus thermophilus into Lactobacillus gasseri. FEMS Microbiol. Lett. 2005, 246:91-101.
15. Caglar E., Cildir S.K., Ergeneli S., Sandalli N., Twetman S. Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Ordontol. Scand. 2006, 64:314-318.
16. Carroll I.M., Andrus J.M., Bruno-Barcena J.M., Klaenhammer T.R., Hassan H.M., Threadgill D.S. The anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase (MnSOD) using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Phyiol. 2007, 293:729-739.
17. Casas I.A., Dobrogosz W.J. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microb. Ecol. Health Dis. 2000, 12:247-285.
18. Chang S.K., Hassan H.M. Characterization of superoxide dismutase in Streptococcus thermophilus. Appl. Environ. Microbiol. 1997, 63:3732-3735.
19. + T cell-mediated skin inflammation. Eur. J. Immunol. 2004, 34:2520-2528.
20. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 2002, 168:171-178.
21. Clancy R. Immunobiotics and the probiotic evolution. FEMS Immunol. Med. Microbiol. 2003, 38:9-12.
22. Collins F.M., Carter P.B. Growth of salmonellae in orally infected germfree mice. Infect. Immun. 1978, 21:41-47.
23. Condon S. Responses of lactic acid bacteria to oxygen. FEMS Microbiol. Rev. 1987, 46:269-280.
24. Connolly E. Lactobacillus reuteri ATCC 55730-A clinically proven probiotic. Nutrafoods 2004, 3:15-22.
25. Connolly E. Lactobacillus reuteri drops-Novel delivery system. Nutrafoods 2005, 4:65-68.
26. Connolly E., Abrahamsson E., Bjorksten B. Safety of d(-)-lactic acid producing bacteria in the human infant. J. Pediatr. Gastroenterol. Nutr. 2005, 41:489-492.
27. De Vrese M., Schrezenmier J. Probiotics, prebiotics, and synbiotics. Adv. Biochem. Eng. Biotechnol. 2008, 111:1-66.
28. de Waard R., Garssen J., Vos J.G., Claassen E. Modulation of delayed-type hypersensitivity and acquired cellular resistance by orally administered viable indigenous lactobacilli in Listeria monocytogenes infected Wistar rats. Lett. Appl. Microbiol. 2002, 35:256-260.
29. Dobrogosz W.J. Enhancement of human health with Lactobacillus reuteri: A probiotic, immunobiotic and immunoprobiotic. Nutrafoods 2005, 4:15-28.
30. Dobrogosz W.J., Roos S. Polyfunctional activities expressed by Lactobacillus reuteri: An immunobiotic species. Nurtafoods 2008, 7:15-25.
31. Drakes M., Blanchard T., Czinn S. Bacterial probiotic modulation of dendritic cells. Infect. Immun. 2004, 72:299-3309.
32. Eom T.-H., Oh E.-Y., Kim Y.-H., Lee H.-S., Yang P.S., Kim J.-T., Lee B.-C. The therapeutic effect of Lactobacillus reuteri in acute diarrhea in infants and todlers. Korean J. Pediatr. 2005, 48:986-989.
33. Francavilla R., Lionetti C.S.P., Magista A.M., Maurogiovanni G., Bucci N., De Canio A., Indiro F., Cavallo L., Ieradi E., Miniello V.L. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: A pilot study (2008). Helicobacter 2008, 13:127-134.
34. Freter R. Fatal enteric cholera infection in the guinea pig achieved by inhibition of the normal enteric flora. J. Inf. Dis. 1956, 104:411-418.
35. Freter R. Chapter 6-Factors affecting the microecology of the gut. Probiotics: The Scientific Basis 1992, Chapman and Hall, London. R. Fuller (Ed.).
36. Fujisawa T., Yaeshima T., Mitsuoka T. Lactobacilli in human feces. Biosci. Microflora 1996, 15:69-75.
37. Fuller R. A Review: Probiotics in man and animals. J. Appl. Bacteriol. 1989, 66:365-378.
38. Fuller R. Chapter 1, History and development of probiotics. Probiotics: The Scientific Basis 1992, Chapman and Hall, London.
39. Probiotics: The Scientific Basis 1992, Chapman and Hall, London. R. Fuller (Ed.).
40. Probiotics 2: Applications and Practical Aspects 1997, Chapman and Hall, London. R. Fuller (Ed.).
41. Gill S.R., Pop M., DeBoy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Reiman D.A., Fraser-Liggeyy C., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
42. Gilliland S.E., Speck M.L. Enumeration and identification of lactobacilli in dietary products. J. Food Protect. 1977, 40:760-767.
43. Glaasker E., Konings W.N., Poolman B. Glycine betaine fluxes in Lactobacillus plantarum during osmostasis and hyper- and hypo-osmotic shock. J. Biol. Chem. 1996, 27:10060-10065.
44. Glaasker E., Konings W.N., Poolman B. Osmotic regulation of intracellular solute pools in Lactobacillus plantarum. J. Bacteriol. 1996, 178:575-582.
45. Glaasker E., Tjan F.S., Ter Steeg P.F., Konings W.N., Poolman B. Physiological response of Lactobacillus plantarum to salt and nonelectrolyte stress. J. Bacteriol. 1998, 180:4718-4723.
46. Glaasker E., Heuberger E.H., Konings W.N., Poolman B. Mechanism of osmotic activation of the quaternary ammonium compound transporter (QacT) of Lactobacillus plantarum. J. Bacteriol. 1998, 180:5540-5546.
47. Glintborg V., Dawids S., Preuss H.J., Winther N.H., Mertz B.A. Long-term administration of Lactobacillus reuteri (ATCC 55730) has no influence on gastric mucosal inflammation and colonization of Helicobacter pylori in humans. A pilot study. Int. J. Probiotics Prebiotics 2006, 1:219-223.
48. Grangette C., Muller-Alouf H., Hols P., Goudercourt D., Delcour J., Turneer M., Mercenier A. Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria. Infect. Immun. 2004, 72:2731-2737.
49. Halliwell B. Oxygen is poisonous: The nature and medical importance of oxygen radicals. Med. Lab. Sci. 1984, 41:157-171.
50. Hart A.l., Lammers K., Brigidi P., Vitali B., Rizzello F., Gionchetti P., Campieri M., Kamm M.A., Knight S.C., Stagg A.J. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004, 53:1602-1609.
51. Havenaar R., Huis in't Veld J.H.J. Probiotics: A general view. The Lactic Acid Bacteria in Health and Disease, Vol. 1 1992, Elsevier Applied Science, New York. B.J.B. Wood (Ed.).
52. Hentges D.H. Gut flora and disease resistance. Probiotics: The Scientific Basis 1992, Chapman and Hall, London. R. Fuller (Ed.).
53. Hoffmann M., Rath E., Holziwimmer G., Quintanilla-Martinez L., Loach D., Tannock G., Haller D. Lactobacillus reuteri 100-23 transiently activates intestinal epithelial cells of mice that have a complex microbiota during early stages of colonization. J. Nutr. 2008, 139:1684-1691.
54. Hols P., Defrenne C., Ferain T., Derzelle S., Delplace B., Delcour J. The alanine racemase gene is essential for growth of Lactobacillus plantarum. J. Bacteriol. 1997, 179:3804-3807.
55. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
56. Imase K., Tanaka A., Tokunaga K., Sugano H., Takahashi S. Lactobacillus reuteri tablets can suppress Helicobacter pylori infection: A double blind, randomized, placebo-controlled cross-over clinical study. J. Jpn. Assoc. Infect. Dis. 2007, 81:387-393.
57. Impey C.S., Mead G.C., George S.M. Competitive exclusion of salmonellas from the chick caecum using a defined mixture of bacterial isolates from the coecal microflora of an adult bird. J. Hyg. 1982, 89:479-490.
58. Indrio F., Riezzo G., Raimondi F., Bisceglia M., Cavallo L., Francavilla R. The effect of probiotics on feeding tolerance, bowel habits, and gastrointestinal moptility in preterm newborns. J. Pediatr. 2008, 152:801-806.
59. Isolauri E., Juntunen M., Rautanen T., Sillanaukee P., Koiulva T. A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991, 88:90-97.
60. Kaila M., Isolauri E., Soppi E., Virtanen E., Laine S., Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res. 1992, 32:141-144.
61. Kankainen M., Paulin L., Tynkkynen S., von Ossowski I., Reunanen J., Partanen P., Satokari R., Vesterlund S., Hendrickx A.P., Lebeer S., De Keersmaecker S.C., Vanderleyden J., et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc. Natl. Acad. Sci. USA 2009, 106:17193-17198.
62. Kehrer J.P. Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 1993, 23:21-48.
63. Kelly D., Campbell J.I., King T.P., Grant G., Janson E.A., Coutts A.G.P., Pettersson S., Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-g and RelA. Nat. Immunol. 2004, 5:104-112.
64. Kelsall B.L., Strober W. Dendritic cells of the gastrointestinal tract. Springer Semin. Immunopathol. 1997, 18:409-420.
65. Klaenhammer T.R., Barrangou R., Buck B.L., Azcarate-Peril M.A., Altermann E. Genomic features of lactic acid bacteria effecting bioprocessing and health. FEMS Microbiol. Rev. 2005, 29:393-409.
66. Kopeloff N. Lactobacillus acidophilus 1926, Williams and Williams, Baltimore.
67. Krasse P., Carlsson B., Dahl C., Paulsson A., Nilsson A., Sinkiewicz G. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed. Dent. J. 2006, 30:55-60.
68. Kullisaar T., Zilmer M., Mikelsaar M., Vihalemm T., Annuk H., Kairane C., Kilk A. Two antioxidative lactobacilli strains as promising probiotics. Int. J. Food Microbiol. 2002, 72:215-224.
69. Lebeer S., Vanderleyden J., De Keersmaecker C.J. Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 2008, 72:728-764.
70. Lederberg J. Of men and microbes. New Perspect. Q. 2004, 21:92-96.
71. Lesser T.D., Molbak L. Better living through microbe action: The benefits of the mammalian gastrointestinal microbiota on the host. Environ. Microbiol. 2009, 11:2194-2206.
72. Ley R.E., Peterson D.A., Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124:837-848.
73. Lionetti E., Miniello V.L., Castellaneta S.P., Magista A.M., De Canio A., Giovanni M., Lerradi E., Cavallo L., Francavilla R. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pyori treatment in children: A randomized placebo controlled trial. Aliment. Pharmacol. Ther. 2006, 24:1461-1468.
74. Livingston M., Loach D., Wilson M., Tannock G.W., Baird M. Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response. Immunol. Cell. Biol. 2009, [Epub ahead of print]. 10.1038/icb.2009.71.
75. Ma D., Forsythe P., Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect. Immun. 2004, 72:5308-5314.
76. Maassen C.B.M., Laman J.D., Boersma W.J.A., Claassen E. Modulation of cytokine expression by lactobacilli, and its possible therapeutic use. Chapter 7. Probiotics 3: Immunomodulation by the Gut Microflora and Probiotics 2000, Kluwer Academic Publishers, London. R. Fuller, G. Perdigon (Eds.).
77. Maassen C.B.M., van Holten-Neelen C., Balk F., den Bak-Glashouwer J.H., Leer R.J., Laman J.D., Boersma W.J.A., Claassen E. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 2000, 18:2613-2623.
78. Madara J. Building an intestine-Architectural contributions of commensal bacteria. N. Engl. J. Med. 2004, 351:1685-1686.
79. Madsen K.L., Doyle J.S., Jewell L.D., Tavernini M.M., Fedorak R.N. Lactobacillus species prevents colitis in interleukin-10 gene-deficient mice. Gastroenterology 1999, 116:107-1114.
80. Madsen K.L., Doyle J.S., Tavernini M.M., Jewell L.D., Rennie R.P., Fedorak R.N. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 2000, 118:1094-1105.
81. Majamaa H., Isolauri E., Saxlin M., Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 1995, 20:333-338.
82. Maldonado G.C., Predigon G. Role of viability of probiotic strains in their persistence in the gut and in mucosal stimulation. J. Appl. Microbiol. 2004, 97:673-681.
83. Marin M.L., Tejada-Simon M.V., Murtha J., Ustunol Z., Pestka J.J. Effects of Lactobacillus spp. on cytokine production by RAW 264.7 macrophage and EL-4 thymoma cell lines. J. Food Prot. 1997, 60:1364-1370.
84. McCarthy J., O'Mahony L., O'Callaghan L., Sheil B., Vaughn E.E., Fitzsimons N., Fitzgibbon J., O'Sullivan G.C., Kiely B., Collins J.K., Shanahan F. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003, 52:975-980.
85. Medzhitov R., Janeway C. Innate immune recognition: Mechanisms and pathways. Immunol. Rev. 2000, 173:89-97.
86. Metchnikoff E. The Prolongation of Life 1907, Optimistic Studies, Heinemann, London.
87. Michail S. Probiotics: Past, present, and future perspectives. Curr. Pediatr. Rev. 2008, 4:96-102.
88. Mitsuoka T. The human gastrointestinal tract (Chapter 4). The Lactic Acid Bacteria in Health and Disease 1992, Vol. 1. Elsevier Applied Science, New York. B.J.B. Wood (Ed.).
89. Mohamadzadeh M., Olson S., Kalina W.V., Ruthel G., Demmin G.L., Warfield K.L., Bavari S., Klaenhammer T.R. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polatization. Proc. Natl. Acad. Sci. USA 2005, 102:2880-2885.
90. Neish A.S., Gewirtz A.T., Zeng H., Young A.N., Hobert M.E., Karmali V., Rao A.S., Madara J.L. Prokaryotic regulation of epithelial responses by inhibition of IκBα ubiquitination. Science 2000, 289:1560-1563.
91. Nikawa H., Makihara S., Fukushima H., Nishimura H., Ozaki Y., Ishida K., Darmawan S., Hamada T., Hara K., Matsumoto A., Tahemoto T., Objectivei R. Lactobacillus reuteri in fermented bovine milk decreases the oral carriage of mutans streptococci. Int. J. Food Microbiol. 2004, 95:219-223.
92. Nurmi I.E., Rantala M. New aspects of Salmonella infection in broiler production. Nature 1973, 241:210-211.
93. O'Hara A.M., Shanahan F. The gut as a forgotten organ. EMBO Rep. 2006, 7:688-693.
94. O'Hara A.M., Shanahan F. Mechanisms of action of probiotics in intestinal diseases. ScientificWorldJournal 2007, 7:31-46.
95. Palumbo E., Favier C.F., Deghorain M., Cocconcelli P.S., Grangette C., Mercenier A., Vaughan E.E., Hols P. Knockout of the alanine racemase gene in Lactobacillus plantarum results in septation defects and cell wall perforation. FEMS Microbiol. Lett. 2004, 233:131-138.
96. Parker R.B. Probiotics, the other half of the antibiotic story. Anim. Nutr. Health 1974, 29:4-8.
97. + T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
98. Peacock T., Bruno-Barcena J.M., Klaenhammer T.R., Hassan H.M. Cloning and heterologous expression of Lactobacillus plantarum CECT 221 (ATCC 14431) Mn-catalase within probiotic lactobacilli 2008, Chapter III of a Ph.D. thesis. Microbiology at NC State University.
99. Pena J.A., Li S.Y., Wilson P.H., Thibodeau S.A., Szary A.J., Versalovic J. Genotypic and phenotypic studies of murine intestinal lactobacilli: Species differences in mice with and without colitis. Appl. Environ. Microbiol. 2004, 70:558-568.
100. Pena J.A., Rogers A.B., Gc Z., Ng V., Li S.Y., Fox J.G., Versalovic J. Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect. Immun. 2005, 73:912-920.
101. Piuri M., Sanchez-Rivas C., Ruzal S. Cell wall modifications during osmotic stress in Lactobacillus casei. J. Appl. Microbiol. 2005, 98:84-95.
102. Powrie F., Maloy K.J. Regulating the regulators. Science 2003, 299:1030-1031.
103. Preidis G.A., Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: Gasteroenterology enters the metagenomics era. Gasterol 2009, 136:2015-2031.
104. Pretzer G., Snel J., Molenaar D., Wiersma A., Bron P.A., Lambert J., de Vos W.M., van der Meer R., Smits M.A., Kleerebezem M. Biodiversity-based identification and functional characterization of the mannose-specific adhesin of Lactobacillus plantarum. J. Bacteriol. 2005, 187:6128-6136.
105. Rakoff-Naholm S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
106. Rastall R.A., Gibson G.R., Gill H.S., Guarner F., Klaenhammer T.R., Pot B., Reid G., Rowland I.R., Sanders M.E. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: An overview of enabling science and potential applications. FEMS Microbiol. Ecol. 2005, 52:145-152.
107. Reid G., Sanders M.E., Gaskins H.R., Gibson G.R., Mercenier A., Rastall R., Roberfroid M., Rowland I., Cherbut C., Klaenhammer T.R. New scientific paradigms for probiotics and prebiotics (consenus report). J. Clin. Gasterol. 2003, 37:105-118.
108. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.-P., Ricciardi-Castagnoli P. Dendtitic cells express tight junction proteins and penetrate gut epithelia monolayers to sample bacteria. Nat. Immunol. 2001, 2:361-367.
109. Rettger L.F., Chaplin H.A. A Treatise on the Transformation of the Intestinal Flora with Special Reference to the Implantation of Bacillus acidiphilus 1921, Yale University Press, New Haven, CT.
110. Rettger L.F., Levy M.N., Weinstein L., Weiss J.E. Lactobacillus acidophilus and Its Therapeutic Application 1935, Yale University Press, New Haven, CT.
111. Reuter G. The Lactobacillus and Bifidobacterium microflora of the human intestine: Composition and succession. Curr. Issues Intest. Microbiol. 2001, 2:43-53.
112. 2 and protection of Lactobacillus bulgaricus from oxidative stress in milk. Appl. Environ. Microbiol. 2006, 72:5143-5149.
113. Rochat T., Bermudez-Humaran L., Gratadoux J.J., Fourage C., Hoebler C., Corthier G., Langella P. Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice. Microb. Cell Fact. 2007, 6:22.
114. Romeo, M. G., Romeo, D. M., Trovato, L., Oliveri, S., Palermo, F., Cota, F., and Betta, P. (2010). Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J. Perinatol. (Epub ahead of print; doi:10.1038/jp 2010.57).
115. Rooks G.A., Adams V., Hunt J., Palmer R., Martinelli R., Brunet L.R. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin. Immunopathol. 2004, 25:237-255.
116. Roy D.G., Klaenhammer T.R., Hassan H.M. Cloning and expression of the manganese superoxide dismutase gene of Escherichia coli in Lactococcus lactis and Lactobacillus gasseri. Mol. Gen. Genet. 1993, 239:33-40.
117. Rutells S., Lemoli R.M. Regulatory T cells and tolerogenic dendritic cells: From basic biology to clinical applications. Immunol. Lett. 2004, 94:11-26.
118. Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J. Clin. Gastroenterol. 2004, 39:S104-S106.
119. Salminen S., Deighton M. Lactic acid bacteria in the gut in normal and disordered states. Dig. Dis. 1992, 10:227-238.
120. Salminen S., Isolauri E., Onnela T. Gut flora in normal and disordered states. Chemotherapy 1995, 41:5-15.
121. Lactic Acid Bacteria 1993, Marcel Dekker, Inc, New York. S. Salminen, A. von Wright (Eds.).
122. Lactic Acid Bacteria: Microbiology and Functional Aspects 1998, Marcel Dekker, Inc, New York. S. Salminen, A. von Wright (Eds.).
123. Savino F., Pelle E., Palumeri E., Oggero R., Miniero R. Lactobacillus reuteri ATCC 55730 versus Simethicone in the treatment of infantile colic: A prospective randomized study. Pediatria 2007, 119:124-130.
124. Schiffrin E.J., Blum S. Interactions between the microbiota and the intestinal mucosa. Eur. J. Clin. Nutr. 2002, 56(S3):S60-S64.
125. Schultz M., Veltkamp C., Dieleman L.A., Grenther W.B., Wyrick P.B., Tonkonogy S.L., Sartor R.B. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis. 2002, 8:71-82.
126. Sheehan V.M., Sleator R.D., Fitzgerald G.F., Hill C. Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118. Appl. Environ. Microbiol. 2006, 72:2170-2177.
127. Sheehan V.M., Sleator R.D., Hill C., Fitzgerald G.F. Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003. Microbiology 2007, 153:3563-3571.
128. Shornikova A.V., Casas A., Isolauri E., Mykkanen H., Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J. Pediatr. Gastroenterol. 1997, 24:399-404.
129. Shornikova A.V., Casas I.A., Mykkanen H., Salo E., Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 1997, 16:1103-1107.
130. Sinkiewicz G., Ljunggren I. Occurance of Lactobacillus reuteri in human breast milk. Microb. Ecol. Health Dis. 2008, 20:122-126.
131. Sleator R.D., Hill C. Patho-biotechnology; using bad bugs to make good bugs better. Sci. Prog. 2007, 90:1-14.
132. Smits H.H., Engering A., van der Kleij D., de Jong E.C., Schipper K., van Capel T.M.M., Zaat B.A.J., Yazdanbakhsh M., Wierenga E.A., Kooyk Y.V., Kapsenberg M.L. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 2005, 115:1260-1267.
133. Snoeyenbos G.H., Weinack O.M., Soejadi A. Protecting chicks and poults from salmonellae by oral administration of normal gut microflora. Avian Dis. 1978, 22:273-278.
134. Snoeyenbos G.H., Weinack O.M., Soejadi A. Competitive exclusion of some pathogens other than salmonellae by native intestinal microflora of chickens. Proceedings of the 22nd World Veterinary Congress, Perth, Australia. 1983, 191.
135. Soejadi A.S., Snoeyenbos G.H., Weinack O.M. Intestinal colonization and competitive exclusion of Campylobacter fetus subsp. jejuni in young chicks. Avian Dis. 1982, 26:520-524.
136. Soejadi-Liem A.S., Snoeyenbos G.H., Weinack O.M. Comparative studies on competitive exclusion of three isolates of Campylobacter fetus subsp. jejuni in chickens by native gut microflora. Avian Dis. 1984, 28:139-146.
137. Soejadi-Liem A.S., Snoeyenbos G.H., Weinack O.M. Establishment and competitive exclusion of Yersenia enterocolitica in the gut of monoxenic and holoxenic chickens. Avian Dis. 1984, 28:256-260.
138. Stagg A.J., Hart A.l., Knight S.C., Kamm M.A. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity. Best Practice Res. Clin. Gasterol. 2004, 18:255-270.
139. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000, 289:1352-1355.
140. Sullivan M.G., Thornton G., O'Sullivan G.C., Collins J.K. Probiotic bacteria: Myth or reality. Trends Food Sci. Tech. 1992, 3:309-314.
141. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
142. Talwalkar A., Kailasapathy K. Metabolic and Biochemical Responses of Probiotic Bacteria to Oxygen. J. Dairy Sci. 2003, 86:2537-2546.
143. Tannock G.W. Genetic manipulation of gut microorganisms. Probiotics: The Scientific Basis 1992, Chapman and Hall, London. R. Fuller (Ed.).
144. Tazume S., Ozawa A., Yamamoto T. Ecological study on the intestinal bacterial flora of patients with diarrhea. Clin. Infect. Dis. 1993, 16:77S-82S.
145. Tejada M.V., Pestka J.J. Proinflammatory cytokine and nitric oxide induction in murine macrophages by cell wall and cytoplasmic extracts of lactic acid bacteria. J. Food Prot. 1999, 62:1435-1444.
146. Tejada M.V., Ustunol Z., Pestka J.J. Ex vivo effects of lactobacilli, streptococci, and bifidobacteria ingestion on cytokine and nitric oxide production in a murine model. J. Food Prot. 1999, 62:162-169.
147. Tubelius P., Stan V., Zachrisson A. Increasing work-place healthiness with the probiotic Lactobacillus reuteri: A randomized, double blind, placebo-controlled study. Environ. Health 2005, 4:25. 10.1186/14676-069X-4-25.
148. Valeur N., Engel P., Carbajal N., Connolly E., Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl. Environ. Microbiol. 2004, 70:1176-1181.
149. von der Weid T., Bulliard C., Schiffrin E.J. Induction by a lactic acid bacterium of a population of CD4 (+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin. Diagn. Lab. Immunol. 2001, 8:695-701.
150. Walter J. Ecological role of lactobacilli in the gastrointestinal tract: Implications for fundamental and biomedical research. Appl. Environ. Microbiol. 2008, 74:4985-4996.
151. Weinack O.M., Snoeyenbos G.H., Smyser C.F., Soejadi A. Competitive exclusion of intestinal colonization of Escherichia coli in chicks. Avian Dis. 1981, 25:696-705.
152. Weizman Z., Asli G., Alsheik A. Effect of a probiotic infant formula on infections in child care centers: Comparison of two probiotic agents. Pediatrics 2005, 115:5-9.
153. Weizman Z., Alsheik A. Safety and tolerance of a probiotic formula in early infancy comparing two probiotic agents: A pilot study. J. Am. Coll. Nutr. 2006, 25:415-419.
154. Wilson K.H. The microecology of Clostridium difficile. Clin. Inf. Dis. 1993, 16:S214-S218.
155. Wolf B.W., Garleb K.A., Ataya D.G., Casas I.A. Safety and tolerance of Lactobacillus reuteri in healthy adult male subjects. Microb. Ecol. Health Dis. 1995, 8:41-50.
156. Wolf B.W., Wheeler K.B., Ataya D.G., Garleb K.A. Safety and tolerance of Lactobacillus reuteri supplementation to population infected with the human immunodediciency virus. Food Chem. Toxicol. 1998, 36:1085-1094.
157. The Lactic Acid Bacteria. The Lactic Acid Bacteria in Health and Disease 1992, Vol. 1. Elsevier Applied Science, New York. B.J.B. Wood (Ed.).